Events

  • riga-295x295

Riga Health Conference – Universal health: Investing in Health and Wellbeing for All

June 29th-30th, 2015 Radison BLU Hotel Latvija, Riga, Latvia

Topics will include:
  • Investing in Efficient European Health Systems which Prevent Disease
  • Ensuring Improved Health Outcomes and Reduced Inequalities
  • Developing Systems for People Centred and Sustainable Health Service Delivery

Programme - Speakers - Request your Invitation

Supporting Partners:
 logos_riga

  • MPNE

Partner Event: MPNE 2015 – The risk of not taking risks in melanoma

24th- 26th April 2015

HOTEL MARIVAUX BRUSSELS
Boulevard Adolphe Max 98
1000 Brussels - Belgium
table-spacer
click here for more info  

  • Vascular-system-343x295

Webinar: MAPPs – New Tools for Decision Making

April 14th, 2:00 pm - 3:00 pm CEST

What is the current status of MAPPs in Europe and the US?

Featuring:
  • Luca Pani, Director General, Italian Medicines Agency
  • Gigi Hirsch, Executive Director, CBI and Program Director, NEWDIGS, MIT, USA
  • James Anderson, Head of Corporate Government Affairs, GlaxoSmithKline, UK
  • Duane Schulthess, Managing Director, Vital Transformation (moderator)
   

News

  • Sarah-Garner copy

Interview: Get Real – Using real world data for decision-making in R&D and health technology assessment

May 20th, 2015|Comments Off on Interview: Get Real – Using real world data for decision-making in R&D and health technology assessment

May 20th, 2015 – by Nuala Moran

Real world evidence holds the potential to both increase efficiency in R&D and to bridge the gap between the proof of efficacy required to pass regulatory scrutiny and the demonstration of […]

  • Luca Pani

Interview with Top Drug Regulator: Adaptive Licensing is a New Paradigm – for Everyone

April 24th, 2015|Comments Off on Interview with Top Drug Regulator: Adaptive Licensing is a New Paradigm – for Everyone

April 24th, 2015 – by Gary Finnegan
Reinventing how medicines come to market demands new thinking from regulators, payors, patients and industry, says Professor Luca Pani, Director General of the Italian Medicines Agency. A full transcript of the interview […]

  • cover-report

Event Report: Launch of European Biopharmaceutical Enterprises (EBE) and Vital Transformation Report, “Europe’s Emerging Science: Putting Advanced Therapies into Practice to Deliver Better Health”

April 21st, 2015|Comments Off on Event Report: Launch of European Biopharmaceutical Enterprises (EBE) and Vital Transformation Report, “Europe’s Emerging Science: Putting Advanced Therapies into Practice to Deliver Better Health”

On 15 April, thought leaders met in Lyon, France to take part in a panel discussion and Q&A on the potential of advanced therapies and the challenges we face in implementing them in Europe. The event marked the launch of the EBE and Vital Transformation report, “Europe’s Emerging Science: Putting Advanced Therapies into Practice to Deliver Better Health”, a guide to advanced therapies.

  • ABPI web logo

Report: The challenges and changes needed to reengineer medicines development in the UK

March 9th, 2015|Comments Off on Report: The challenges and changes needed to reengineer medicines development in the UK

A new report from the ABPI and Vermilion Life Sciences examines the challenges and changes needed for the UK to lead reengineering medicines development, and proposes a new methodology to achieve this.